Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 227-217-5 | CAS number: 5718-26-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Macrolex Orange R is not toxic in acute oral and inhalation studies.
In the acute oral study 5 male and 5 female Wistar rates were dosed with 5000 mg/kg test item. No symptoms or mortality were observed. Consequently the discriminating dose is 5000 mg/kg (highest dose tested).
A study on the acute inhalation toxicity of Macrolex Orange R on rats has been conducted in accordance with OECD Test Guideline no. 403 (2009). The reparability of the aerosol was adequate and in compliance with the test guidelines [the mass median aerodynamic diameter (MMAD) was 3.70 µm, the geometric standard deviation (GSD) was 2.14]. Rats exposed to the test item did not show clinical signs at 2441 mg/m³. During the clinical observation test item-dependent orange discoloration was seen on nose and muzzle as well as on the head and forelegs. No findings were seen at the functional observation battery. No toxicological relevant test item-related changes in incremental body weight gain were observed. Significantly decreased body temperatures were found in animals exposed to 2441 mg/m³ test item when compared to the control animals. Mortality did not occur at 2441 mg/m³. No gross-pathological findings were observed at necropsy in animals exposed to 2441 mg/m³ Macrolex Orange R.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1983
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- 5 male and 5 female Wistar rates were dosed with 5000 mg/kg test item and a volume of 20 ml/kg; vehicle: Lutrol. Animals were observed for 14 days.
- GLP compliance:
- no
- Test type:
- other: Limit test with 5000 mg/kg
- Limit test:
- yes
- Specific details on test material used for the study:
- Macrolex Orange 51032 (Oek.-Nr.: 826-152)
Solid powder - Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 5 male and 5 female Wistar rates were dosed with 5000 mg/kg test item and a volume of 20 ml/kg; vehicle: Lutrol. Animals were observed for 14 days.
- Route of administration:
- oral: gavage
- Vehicle:
- other: Lutrol
- Details on oral exposure:
- 5 male and 5 female Wistar rates were dosed with 5000 mg/kg test item and a volume of 20 ml/kg; vehicle: Lutrol. Animals were observed for 14 days.
- Doses:
- 5000 mg/kg
- No. of animals per sex per dose:
- 5 male and 5 female Wistar rates
- Control animals:
- no
- Details on study design:
- 5 male and 5 female Wistar rates were dosed with 5000 mg/kg test item and a volume of 20 ml/kg; vehicle: Lutrol. Animals were observed for 14 days.
- Statistics:
- no
- Key result
- Sex:
- male/female
- Dose descriptor:
- discriminating dose
- Effect level:
- 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- no
- Clinical signs:
- other: no effect
- Gross pathology:
- no effect
- Other findings:
- no
- Interpretation of results:
- GHS criteria not met
- Executive summary:
In the acute oral study 5 male and 5 female Wistar rates were dosed with 5000 mg/kg test item. No symptoms or mortality were observed. Consequently the discriminating dose is 5000 mg/kg (highest dose tested)
Reference
Mortality: 0/10
Symthomes: 0/10
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed concentration procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Three male and three female rats were simultaneously exposed under nose-only conditions for 4 h. This procedure is in compliance with the limit test described in OECD Test Guideline No. 403 and OECD GD#39 (2009).
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- clean air
- Mass median aerodynamic diameter (MMAD):
- 3.7 µm
- Geometric standard deviation (GSD):
- 2.14
- Remark on MMAD/GSD:
- Primary goal of the limit test is to generate an aerosol with a MMAD between 1-4 µm at 2000 mg/m³. Aerosol testing at greater than 2000 mg/m³ should only be attempted if a respirable particle size is achievable. Consequently animals were exposed to 2441 mg/m³ of an aerosol with a MMAD of 3.70 µm. Higher concentrations have been tested in pretest without animals and resulted in MMAD >4 µm.
- Details on inhalation exposure:
- Gravimetric analysis of filter samples and the real-time monitoring of the aerosol test atmosphere from the breathing zone area indicated that the exposure conditions were temporally stable over the 4-h exposure period.
Analysis of the aerosol particle-size distribution from the breathing zone samples demonstrates that the aerosol generated was in the respirable range. Repeated measurements made during one exposure demonstrated temporally stable particle-size distributions. The total gravimetric concentration recovered by the cascade impactor was similar to that concentration found by filter analyses. From this finding it can be concluded that interstage wall losses occurring within the low-pressure critical orifice cascade impactor or potential anisokinetic sampling errors appear to be negligible.
Temperature values in the inhalation chamber were in the range suggested by the testing guidelines. Humidity values were lower than suggested by the test guidelines due to the use of dry pressurized air for particle dispersion. This deviation from the guideline had no apparent negative impact on the outcome of study. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 2441 mg/m³
- No. of animals per sex per dose:
- 3 males and 3 females
- Control animals:
- yes
- Details on study design:
- A study on the acute inhalation toxicity of Macrolex Orange R (henceforward referred to as test item) on rats has been conducted in accordance with OECD Test Guideline no. 403 (2009). Test procedures were adapted so as to comply also with the Method B.2 of the Annex to Regulation (EC) No 440/2008, and especially OECD Guidance Document no. 39 (2009). One group of rats was nose-only exposed to the solid aerosol of the test item at 2441 mg/m³. This procedure is in accordance with the limit test of the OECD Test Guideline no. 403 (2009). Primary goal of the limit test is to generate an aerosol with a MMAD between 1-4 µm at 2000 mg/m³. Aerosol testing at greater than 2000 mg/m³ should only be attempted if a respirable particle size is achievable. Consequently animals were exposed to 2441 mg/m³ of an aerosol with a MMAD of 3.70 µm. Higher concentrations have been tested in pretest without animals and resulted in MMAD >4 µm. Rats exposed to dry conditioned air only under otherwise identical circumstances served as controls.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- 2 441 mg/m³ air (analytical)
- Based on:
- act. ingr.
- Exp. duration:
- 4 h
- Mortality:
- no
- Clinical signs:
- other: During the clinical observation test item-dependent orange discoloration was seen on nose and muzzle as well as on the head and forelegs. No findings were seen at the functional observation battery.
- Body weight:
- No toxicological relevant test item-related changes in incremental body weight gain were observed.
- Gross pathology:
- No gross-pathological findings were observed
- Other findings:
- Significantly decreased body temperatures were found in animals exposed to 2441 mg/m³ test item when compared to the control animals.
- Interpretation of results:
- GHS criteria not met
- Executive summary:
A study on the acute inhalation toxicity of Macrolex Orange R (henceforward referred to as test item) on rats has been conducted in accordance with OECD Test Guideline no. 403 (2009). Test procedures were adapted so as to comply also with the Method B.2 of the Annex to Regulation (EC) No 440/2008, and especially OECD Guidance Document no. 39 (2009). One group of rats was nose-only exposed to the solid aerosol of the test item at 2441 mg/m³. This procedure is in accordance with the limit test of the OECD Test Guideline no. 403 (2009). Primary goal of the limit test is to generate an aerosol with a MMAD between 1-4 µm at 2000 mg/m³. Aerosol testing at greater than 2000 mg/m³ should only be attempted if a respirable particle size is achievable. Consequently animals were exposed to 2441 mg/m³ of an aerosol with a MMAD of 3.70 µm. Higher concentrations have been tested in pretest without animals and resulted in MMAD >4 µm. Rats exposed to dry conditioned air only under otherwise identical circumstances served as controls. The results can be summarized as follows:
LC50 inhalation (aerosol, 4 h)
LC50: >2441 mg/m³ test item
The respirability of the aerosol was adequate and in compliance with the test guidelines [the mass median aerodynamic diameter (MMAD) was 3.70 µm, the geometric standard deviation (GSD) was 2.14]. Rats exposed to the test item did not show clinical signs at 2441 mg/m³. During the clinical observation test item-dependent orange discoloration was seen on nose and muzzle as well as on the head and forelegs. No findings were seen at the functional observation battery. No toxicological relevant test item-related changes in incremental body weight gain were observed. Significantly decreased body temperatures were found in animals exposed to 2441 mg/m³ test item when compared to the control animals. Mortality did not occur at 2441 mg/m³. No gross-pathological findings were observed at necropsy in animals exposed to 2441 mg/m³ Macrolex Orange R.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating conc.
- Value:
- 2 441 mg/m³ air
Additional information
no study available
Justification for classification or non-classification
The discriminating dose in an acute oral toxicity study was 5000 mg/kg (highest dose tested) and the discriminationg concentration in an acute inhalation study was 2441 mg/m³ (highest concentration tested). No calssification is warrented.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.